|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-3-20
|
|
pubmed:abstractText |
Diabetes mellitus (DM) affects an estimated 175 million people world-wide. Approximately one-third of patients with DM have toenail onychomycosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
254-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11903236-Adolescent,
pubmed-meshheading:11903236-Adult,
pubmed-meshheading:11903236-Aged,
pubmed-meshheading:11903236-Antifungal Agents,
pubmed-meshheading:11903236-Blood Glucose,
pubmed-meshheading:11903236-Diabetes Mellitus, Type 1,
pubmed-meshheading:11903236-Diabetes Mellitus, Type 2,
pubmed-meshheading:11903236-Drug Interactions,
pubmed-meshheading:11903236-Female,
pubmed-meshheading:11903236-Follow-Up Studies,
pubmed-meshheading:11903236-Foot Dermatoses,
pubmed-meshheading:11903236-Humans,
pubmed-meshheading:11903236-Hypoglycemic Agents,
pubmed-meshheading:11903236-Male,
pubmed-meshheading:11903236-Middle Aged,
pubmed-meshheading:11903236-Naphthalenes,
pubmed-meshheading:11903236-Onychomycosis,
pubmed-meshheading:11903236-Prospective Studies
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial.
|
|
pubmed:affiliation |
Department of Dermatology, Pécs University Medical Centre, Kodály u. 20, H-7624 Pécs, Hungary. farkasb@derma.pote.hu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
